Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 250 participants.
Also called NCT02777593
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT02777593
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Results first posted
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT02777593. Non-randomized; no masking; primary purpose treatment. Start 2016-09-06 (actual); primary completion 2021-04-12 (actual). Results posted on 2022-11-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2
- Acronym
- SSB 11-02
- Condition
- Aortic Aneurysm, Thoracic
- Condition
- Aorta; Lesion
- Intervention (Device)
- GORE® TAG® Thoracic Branch Endoprosthesis
- Lead sponsor
- W.L.Gore & Associates
Record details
- Record id
cardio:ct-nct02777593- Content hash
3053c7e4c802eef7aff50ee47bfeafc406d6b6e55c4a56953a0ff6b4fc7bb324